The Air Pressure Therapy Market is estimated to be valued at US$ 4.4 Billion in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Air Pressure Therapy involves the use of pneumatic compression devices, which apply pressure to specific body parts to enhance blood circulation, relieve pain, reduce swelling, and promote healing. These devices are widely used in the treatment of various medical conditions such as lymphedema, deep vein thrombosis, and chronic wounds.
The growth of the Global Air Pressure Therapy Market is primarily driven by the rising prevalence of chronic diseases, such as diabetes and obesity, which increases the risk of developing circulatory system disorders. Furthermore, the growing geriatric population and the increasing adoption of non-invasive treatment options are also contributing to market growth.
Another driver for market growth is the technological advancements in air pressure therapy devices, such as the development of portable and user-friendly devices that offer better patient comfort and convenience. Additionally, the increasing healthcare expenditure and the expanding healthcare infrastructure in developing economies are further augmenting the market growth.
Market Key Trends:
One key trend in the Air Pressure Therapy market is the increasing prevalence of chronic diseases such as deep vein thrombosis (DVT), lymphedema, and chronic venous insufficiency. These conditions often require the use of compression therapy to improve blood circulation and reduce swelling. The rising incidence of these diseases, coupled with the growing aging population, is driving the demand for air pressure therapy devices.
Strength: Air pressure therapy is a non-invasive and effective treatment option for various chronic conditions. It offers benefits such as improved blood flow, reduced swelling, and pain relief.
Weakness: The high cost of air pressure therapy devices and the lack of reimbursement for some conditions may limit the adoption of this treatment option, especially in developing regions.
Opportunity: The increasing focus on home healthcare and the development of portable and user-friendly air pressure therapy devices create opportunities for market expansion.
Threats: The presence of alternative treatment options such as medications and surgeries, as well as the lack of awareness among physicians and patients about the benefits of air pressure therapy, pose threats to market growth.
The global Air Pressure Therapy market is expected to witness high growth, exhibiting a CAGR of 6.3% over the forecast period. The market is driven by the increasing prevalence of chronic diseases and a growing aging population. North America is expected to be the fastest-growing and dominating region, driven by the high incidence of chronic diseases and the presence of key market players in the region.
Key players operating in the Air Pressure Therapy market include DJO Global, Inc., BSN medical (now part of Essity), Smith & Nephew plc, medi GmbH & Co. KG, SIGVARIS Group, Bio Compression Systems, Inc., Tactile Medical, RIKEN SEIKI CO., LTD., Paul Hartmann AG, 3M Company, Gottfried Medical, Inc., Mego Afek AC Ltd., Abov Semiconductor, Persys Medical, BTL Industries, Human Meditek Co., Ltd., Huntleigh Healthcare Limited (part of Arjo), KCI Licensing, Inc., Beijing Huibo Medical Device Co., Ltd., and Bioinicia S.L. These key players are focused on product development, strategic collaborations, and expansion to enhance their market presence and gain a competitive advantage in the industry.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it